Cholesterol embolization syndrome following thrombolysis during acute myocardial infarction

Herz. 2012 Mar;37(2):231-3. doi: 10.1007/s00059-011-3442-7. Epub 2011 May 14.

Abstract

Background: Cholesterol embolization syndrome (CES) is the result of atherosclerotic plaque erosion and subsequent dislodgement of cholesterol crystals from the core of the plaque to the peripheral arteries. The source of emboli is usually located in the aorta, whereas the most commonly affected organs are the skin and the kidneys.

Case report: The case of a 69-year-old male with cyanotic painful discoloration of his toes following thrombolysis for acute myocardial infarction 1 month previously is presented. Both transesophageal echocardiography and magnetic resonance aortography showed a diffuse ulcerated atherosclerotic plaque in the course of descending thoracic aorta, while a skin biopsy of the cyanotic toes revealed cholesterol crystals in the lumen of the small diameter arteries.

Conclusion: Cholesterol embolizations from the aorta are difficult to treat and may end in renal failure. Since treatment options are limited without proven efficacy, increased awareness by the clinicians is needed.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Embolism, Cholesterol / chemically induced*
  • Embolism, Cholesterol / diagnosis
  • Embolism, Cholesterol / prevention & control*
  • Fibrinolytic Agents / adverse effects*
  • Humans
  • Male
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / therapy*
  • Thrombolytic Therapy / adverse effects*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents